Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes.
about
AP@home: The Artificial Pancreas Is Now at HomeAP@home: a novel European approach to bring the artificial pancreas home.Analysis of insulin in human breast milk in mothers with type 1 and type 2 diabetes mellitusPeriodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients.Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-SetClosed-loop insulin delivery: from bench to clinical practice.Can glucose be monitored accurately at the site of subcutaneous insulin delivery?Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.What Are the Next Steps in Continuous Glucose Monitoring?Lipohypertrophy and the artificial pancreas: is this an issue?Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time.Systematic in vivo evaluation of the time-dependent inflammatory response to steel and Teflon insulin infusion catheters.An Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation.
P2860
Q30354088-87A31F9D-6A23-4A44-A6A6-2BC263C1CB45Q30424293-30D37600-5BC3-4B8C-B0DB-747462FC2019Q35829799-7F6C5FEC-D114-4915-83C0-8462C2042040Q36520583-8110B9CD-19E6-4877-AB09-B3C66035997CQ37080640-438B3387-F894-48BE-B623-9C2BCF9E4080Q37846089-04E2012F-4C49-45C3-972A-9F3D938C676FQ38215999-4971B860-DA6C-4E7A-94D5-065FF669B7CDQ38750029-9D43FE6B-57AD-4B50-BD08-FC8ECC360D7BQ42723977-C4C4A30F-5F46-4809-8F0A-E748BF3B30DCQ42724240-995D9274-7804-4386-80A8-84BA5CFF2467Q43094790-C959642D-A17F-4538-9217-1F14710E45F6Q49951304-4DA3B5A8-B3CE-486E-93E6-DCFE4A7501D4Q50995990-6B71FC53-B6A0-457B-AE5B-872EB59D356D
P2860
Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Use of the site of subcutaneou ...... patients with type 1 diabetes.
@ast
Use of the site of subcutaneou ...... patients with type 1 diabetes.
@en
type
label
Use of the site of subcutaneou ...... patients with type 1 diabetes.
@ast
Use of the site of subcutaneou ...... patients with type 1 diabetes.
@en
prefLabel
Use of the site of subcutaneou ...... patients with type 1 diabetes.
@ast
Use of the site of subcutaneou ...... patients with type 1 diabetes.
@en
P2093
P2860
P356
P1433
P1476
Use of the site of subcutaneou ...... patients with type 1 diabetes.
@en
P2093
Gerd Köhler
Hans Köhler
Lukas Schaupp
Martin Ellmerer
Ofer Yodfat
Roland Schaller
Ruthy Kaidar
Stefan Korsatko
Stefan Lindpointner
Thomas R Pieber
P2860
P304
P356
10.2337/DC09-1532
P407
P577
2009-12-29T00:00:00Z